Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Exercise of options, PDMR transaction and TVR

July 7, 2021
RNS Number : 3722E Renalytix PLC 07 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Exercise of options, PDMR transaction and TVR   NEW YORK , 7 July, 2021 - The Board of   Renalytix plc (LSE: RENX) announces that it has issued and allotted 27,500 ordinary shares of 0.25 pence

Directorate Change

July 1, 2021
RNS Number : 9118D Renalytix PLC 01 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Death of Director     NEW YORK , 1 July, 2021 - The Board of   Renalytix plc (LSE: RENX) (NASDAQ: RNLX) is saddened to announce the death of Dr. Barbara Murphy , Non-Executive Director and

Total Voting Rights

July 1, 2021
RNS Number : 7147D Renalytix PLC 01 July 2021   Renalytix plc   (" Renalytix " or the " Company ")     Total voting rights   The Company's total issued share capital consists of 72,197,286 shares of 0.25 pence each, with each share carrying the right to one vote.

Director/PDMR Shareholding

June 28, 2021
RNS Number : 3397D Renalytix PLC 28 June 2021   Renalytix plc    ("Renalytix" or the "Company")   Director/PDMR Dealing   The Company had been informed today that Christopher Mills , a non-executive director and interim Chairman, completed the sale of 6,100 ordinary shares of 0.25 pence each

New data for KidneyIntelX

June 28, 2021
RNS Number : 2844D Renalytix PLC 28 June 2021   Renalytix plc   (" Renalytix " or the " Company ")     KidneyIntelX TM Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time   Study Results lay foundation for KidneyIntelX repeat testing, reimbursement, and

Director/PDMR Dealing

June 25, 2021
RNS Number : 2249D Renalytix PLC 25 June 2021     Renalytix plc    ("Renalytix" or the "Company")   Director/PDMR Dealing   The Company was informed that today, Fergus Fleming , Chief Technology Officer, completed the sale of 15,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the

Exercise of options

June 25, 2021
RNS Number : 1945D Renalytix PLC 25 June 2021   Renalytix plc   (" Renalytix " or the " Company ")     Exercise of options and total voting rights   NEW YORK , June 25, 2021 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces that it has issued and allotted 150,000 ordinary shares of 0.25 pence

Change of name

June 24, 2021
RNS Number : 0409D Renalytix AI PLC 24 June 2021   Renalytix AI plc   (" Renalytix " or the " Company ")     Change of name to Renalytix Plc Change of registered office Change of website   NEW YORK , June 24, 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) announces it has changed its name to

Director/PDMR Shareholding - Replacement

June 22, 2021
RNS Number : 7366C Renalytix AI PLC 22 June 2021   The following amendment(s) has been made to the ' Director/PDMR Dealing ' announcement released on 22 June 2021 at 10:57 under RNS No 7062C.   The price of 113.5 pence per share was incorrect and has been amended to 1135 pence per share.

Director/PDMR Shareholding

June 22, 2021
RNS Number : 7062C Renalytix AI PLC 22 June 2021   Renalytix AI plc    ("Renalytix" or the "Company") Director/PDMR Dealing The Company was informed that today, Christopher Mills , a non-executive director and interim Chairman, completed the sale of 17,000 ordinary shares of 0.25 pence each
Displaying 41 - 50 of 183